Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia
Clinical trial NCT02996474 · COMPLETED
Trial details
- NCT number
- NCT02996474
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-16
- Primary completion
- 2019-04-02
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.